Related Experiment Videos
Theromin, a novel leech thrombin inhibitor
1Laboratoire d'Endocrinologie des Annélides, Unité Propre de la Recherche Supérieure Associée au CNRS 8017 CNRS, SN3, Université des Sciences et Technologie de Lille, F-59655 Villeneuve d'Ascq Cedex, France. michel.salzet@univ-lille1.fr
The Journal of Biological Chemistry
|June 6, 2000
Summary
Researchers purified theromin, a potent thrombin inhibitor from the Theromyzon tessulatum leech. This novel inhibitor shows promise for biomedical applications by reducing inflammatory cell activation.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Thrombin plays a critical role in hemostasis and thrombosis.
- Development of potent and specific thrombin inhibitors is crucial for treating thrombotic disorders.
- Natural sources are being explored for novel anticoagulant compounds.
Purpose of the Study:
- To purify and characterize the most potent thrombin inhibitor from the leech Theromyzon tessulatum.
- To elucidate the primary sequence and structural properties of the inhibitor.
- To evaluate the inhibitor's effect on inflammatory cell activation.
Main Methods:
- Purification using gel permeation, anion exchange chromatography, and high-performance liquid chromatography (HPLC).
- Primary sequence determination via reduction, s-beta-pyridylethylation, Edman degradation, trypsin digestion, and mass spectrometry.
- Assessment of inhibitory activity against thrombin.
- Evaluation of effects on lipopolysaccharide-induced human granulocyte and monocyte activation.
Main Results:
- Isolation and purification of a novel thrombin inhibitor, designated theromin.
- Theromin is a homodimer composed of 67 amino acid residues with 16 cysteine residues.
- No sequence homology was found between theromin and other known thrombin inhibitors.
- Theromin demonstrated dose-dependent inhibition of human granulocyte and monocyte activation.
Conclusions:
- Theromin is a novel, potent thrombin inhibitor with a unique sequence.
- Its ability to inhibit inflammatory cell activation suggests potential therapeutic applications beyond anticoagulation.
- Theromin holds significant biomedical promise for treating thrombotic and inflammatory conditions.